HilleVax, Inc. (HLVX)
NASDAQ: HLVX · Real-Time Price · USD
1.850
-0.070 (-3.65%)
At close: Jun 13, 2025, 4:00 PM
1.851
+0.001 (0.04%)
After-hours: Jun 13, 2025, 4:46 PM EDT
HilleVax Market Cap
HilleVax has a market cap or net worth of $91.77 million as of June 13, 2025. Its market cap has decreased by -84.71% in one year.
Market Cap
91.77M
Enterprise Value
-43.73M
1-Year Change
-84.71%
Ranking
Category
Stock Price
$1.85
Market Cap Chart
Since the IPO on April 29, 2022, HilleVax's market cap has decreased from $538.26M to $91.77M, a decrease of -82.95%. That is a compound annual growth rate of -43.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 91.77M | -8.09% |
| Dec 31, 2024 | 99.85M | -86.63% |
| Dec 29, 2023 | 746.58M | 25.20% |
| Dec 30, 2022 | 596.32M | 10.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.57B |
| Johnson & Johnson | 377.99B |
| Novo Nordisk | 355.28B |
| AbbVie | 337.52B |
| UnitedHealth Group | 284.42B |
| Abbott Laboratories | 235.96B |
| Novartis AG | 234.52B |
| AstraZeneca | 231.58B |